Detalhe da pesquisa
1.
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial.
Ann Surg Oncol
; 31(6): 4073-4083, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459418
2.
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Int J Cancer
; 148(6): 1478-1488, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33038277
3.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982686
4.
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.
Hematol Oncol
; 38(3): 244-256, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067259
5.
ASO Visual Abstract: Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer-The Randomized Multicenter Phase II NEPAFOX Trial.
Ann Surg Oncol
; 31(6): 4121-4122, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575722
6.
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
Ann Hematol
; 98(4): 897-907, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610279
7.
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer.
Br J Cancer
; 119(3): 296-302, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29988111
8.
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Lancet Oncol
; 17(12): 1697-1708, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27776843
9.
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial.
BMC Cancer
; 13: 454, 2013 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24090011
10.
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML.
Trials
; 22(1): 765, 2021 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732236
11.
CNS Hodgkin lymphoma.
Blood
; 112(5): 1658-61, 2008 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18591379
12.
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment.
Cancer Med
; 9(14): 4991-5007, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436621
13.
Pancreatic carcinosarcoma. Case report of multimodal therapy and review of the literature.
JOP
; 9(1): 50-5, 2008 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-18182744
14.
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.
Leukemia
; 32(12): 2558-2571, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30275528
15.
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
J Clin Oncol
; 36(20): 2024-2034, 2018 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29750632
16.
Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation.
Cytometry B Clin Cytom
; 72(4): 241-8, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17266149
17.
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer.
J Clin Oncol
; 23(23): 5314-22, 2005 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15955899
18.
Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia.
Eur J Cancer
; 42(17): 2893-6, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16950614
19.
Incidence of monoclonal B-cell disease in siblings of patients with multiple myeloma.
Haematologica
; 91(2): 274-6, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16461322
20.
Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer.
Clin Cancer Res
; 11(13): 4843-50, 2005 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16000582